EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

From iron to HIF-PH inhibitors: rethinking anemia management after kidney transplant

Anna De Amici, Chiara De Liso, Anna Pisacreta, Margherita Di Naro, Lara Caldiroli, Paolo Molinari, Anna Regalia, Emilietta Brigati, Simona Verdesca, Marco Maggi, Matteo Tommaso Righi, Michele Filippi und 2 weitere

Giornale di Clinica Nefrologica e Dialisi · 25.06.2026 · 38 (1) · 100-106

DOI: 10.33393/gcnd.2026.3718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Giornale di Clinica Nefrologica e Dialisi, online erschienen am 25.06.2026. Verfasst von Anna De Amici und 13 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemia is one of the most common complications in patients undergoing kidney transplantation, with an estimated prevalence between 30% and 50%, especially in the first six months after transplantation. The pathogenesis of anemia in these patients is multifactorial, related to chronic inflammation, disorders of iron metabolism, myelosuppression from several immunosuppressive drugs, and hormonal and metabolic alterations. The clinical implications of anemia in kidney transplants are significant: it is a negative prognostic factor for patient and transplant survival, significantly affecting cardiovascular risk and quality of life. This review analyzes in detail the pathogenic mechanisms of anemia in the post-transplant context, illustrating their clinical impact and providing an updated overview of currently available therapeutic strategies, with a focus on new molecules belonging to the class of prolyl-hydroxylase inhibitors (HIF-PHi), which are revolutionizing the therapeutic approach to anemia secondary to renal failure.

Zitieren

APA

Amici, A. D., Liso, C. D., Pisacreta, A., Naro, M. D., Caldiroli, L., Molinari, P., Regalia, A., Brigati, E., Verdesca, S., Maggi, M., Righi, M. T., Filippi, M., Castellano, G., & Alfieri, C. (2026). From iron to HIF-PH inhibitors: rethinking anemia management after kidney transplant. Giornale di Clinica Nefrologica e Dialisi, 38(1), 100-106. https://doi.org/10.33393/gcnd.2026.3718

Vancouver

Amici AD, Liso CD, Pisacreta A, Naro MD, Caldiroli L, Molinari P, et al. From iron to HIF-PH inhibitors: rethinking anemia management after kidney transplant. Giornale di Clinica Nefrologica e Dialisi. 2026;38(1):100-106. doi:10.33393/gcnd.2026.3718

BibTeX
@article{Amici2026,
  author = {Amici, Anna De and Liso, Chiara De and Pisacreta, Anna and Naro, Margherita Di and Caldiroli, Lara and Molinari, Paolo and Regalia, Anna and Brigati, Emilietta and Verdesca, Simona and Maggi, Marco and Righi, Matteo Tommaso and Filippi, Michele and Castellano, Giuseppe and Alfieri, Carlo},
  title = {From iron to HIF-PH inhibitors: rethinking anemia management after kidney transplant},
  journal = {Giornale di Clinica Nefrologica e Dialisi},
  year = {2026},
  volume = {38},
  number = {1},
  pages = {100--106},
  doi = {10.33393/gcnd.2026.3718}
}
Kostenlos starten →